“Your epigenetics can be changed.” - Eric Marcotulli, CEO, at The Longevity Show
Plus: Leonard Guarente, Ph.D. at TEDxMIT, the truth about peptides, and Mosaic in Women’s Health.
Elysium Health shares new perspectives on longevity science, featuring CEO Eric Marcotulli's discussion on personalized approaches to healthspan at The Longevity Show. The company highlights breakthrough data on long-term NAD+ boosting and epigenetic clocks, emphasizing the potential to change epigenetics and measure aging. Elysium also showcases its co-founder's TEDxMIT talk on sirtuins and NAD+.
Read this email as text
for screen readers, or when images don't load
Thank you for reading our August newsletter. This month’s edition is 874 words, about a 3-minute read.
Want to get the Elysium Newsletter in your inbox? Sign up here.
Volume 10, Issue 8
As late summer sets in, we’re sharing new perspectives on some of the questions shaping longevity science today. Elysium co-founder and Chief Scientist Leonard Guarente, Ph.D., traces three decades of research into sirtuins and NAD+ in a new TEDxMIT talk; CEO Eric Marcotulli joins The Longevity Show to discuss biological age and personalized approaches to healthspan; and Chief Medical Officer Omar Baker, M.D., explains the evolving landscape of peptide regulation in NewBeauty. Plus, Elysium appeared across leading publications, with Mosaic featured in Women’s Health and Creatine+ named an editor favorite by Harper’s BAZAAR.
THE LONGEVITY SHOW™ talks personalized longevity care with Eric Marcotulli, CEO
THE LONGEVITY SHOW™
Archived for reference and commentary. Elysium Health, its logos and content are the property of their respective owners; Inbox Archive claims no affiliation and has disabled all links. If you own this content and would like it removed, get in touch.
Similar campaigns from other brands
Different brands running the same play. Compare any of them side by side.
